Evofem Biosciences, Inc. Uncategorized Contracts & Agreements
34 Contracts & Agreements
- Definitive Agreement by and between the Company and Aditxt, Inc (Filed With SEC on December 12, 2023)
- Form of Restructuring Agreement (Filed With SEC on December 7, 2023)
- Offer Letter, by and between the Registrant and Ivy Zhang, dated as of April 10, 2023 (Filed With SEC on June 16, 2023)
- Form of Right (Filed With SEC on September 16, 2022)
- Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 10, 2022)
- Evofem Biosciences, Inc (Filed With SEC on March 4, 2021)
- Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 4, 2021)
- Letter Agreement, dated as of October 14, 2020, by and between Evofem Biosciences, Inc., Adjuvant Global Health Technology Fund, L.P. and Adjuvant Global Health Technology Fund... (Filed With SEC on October 15, 2020)
- Description of Evofems securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934 (Filed With SEC on March 12, 2020)
- Form of Repricing Letter Agreement (Filed With SEC on February 11, 2019)
- Form of Repricing Letter Agreement (Filed With SEC on February 11, 2019)
- Twelfth Amendment, dated as of December 4, 2017, by and between Neothetics, Inc. and LJ Gateway Office LLC (Filed With SEC on December 8, 2017)
- Consent to Sub-Sublease, dated as of January 30, 2015, by and among Evofem Biosciences, Inc., Kilroy Realty, L.P., Relational Investors LLC and WomanCare Global Trading, Inc (Filed With SEC on November 15, 2017)
- Side Letter, dated as of October 11, 2017, by and between Evofem Biosciences, Inc. and Woodford Investment Management Limited (Filed With SEC on November 15, 2017)
- Amended Offer Letter, dated as of November 16, 2015, by and between the Evofem Biosciences, Inc. and Justin J. File (Filed With SEC on November 15, 2017)
- Offer Letter, dated as of March 8, 2015, as amended, by and between Evofem Biosciences, Inc. and Justin J. File (Filed With SEC on November 15, 2017)
- Offer Letter, dated as of October 16, 2014, by and between Evofem Biosciences, Inc. and Saundra Pelletier (Filed With SEC on November 15, 2017)
- Offer Letter, dated as of April 15, 2015, by and between Evofem Biosciences, Inc. and Kelly Culwell, M.D (Filed With SEC on November 15, 2017)
- Second Amendment to Stockholder Agreement, dated as of July 28, 2017, by and among Evofem Biosciences, Inc. and the stockholders of Evofem Biosciences, Inc. listed therein (Filed With SEC on November 15, 2017)
- First Amendment to Stockholder Agreement, dated as of July 13, 2016, by and among Evofem Biosciences, Inc. and the stockholders of Evofem Biosciences, Inc. listed therein (Filed With SEC on November 15, 2017)
- Stockholder Agreement, dated as of November 25, 2015, by and among Evofem Biosciences, Inc. and the stockholders of Evofem Biosciences, Inc. listed therein (Filed With SEC on November 15, 2017)
- Form of Lock-Up Agreement (Filed With SEC on October 17, 2017)
- Form of Support Agreement, by and between Evofem Biosciences, Inc. and certain of its stockholders (Filed With SEC on October 17, 2017)
- ELEVENTH AMENDMENT (Filed With SEC on February 14, 2017)
- SECOND AMENDMENT (Filed With SEC on May 12, 2016)
- SECOND AMENDMENT (Filed With SEC on April 1, 2016)
- NEOTHETICS, INC. STOCKOPTION AGREEMENT (Filed With SEC on November 10, 2014)
- FIRST AMENDMENT (Filed With SEC on November 10, 2014)
- Additional abbreviations may also be used though not in the above list. (Filed With SEC on November 10, 2014)
- LITHERA, INC. 9191 Towne CentreDrive San Diego, CA 92122 August 12, 2014 (Filed With SEC on October 17, 2014)
- LITHERA, INC. 9191 Towne CentreDrive San Diego, CA 92122 July 3, 2014 (Filed With SEC on October 17, 2014)
- NINTH AMENDMENT (Filed With SEC on October 17, 2014)
- CONTRACT NO. 0702/12 (Filed With SEC on October 17, 2014)
- DECEMBER 12, 2012 TECHNOLOGY TRANSFER AGREEMENT By and Between DOMAIN RUSSIAINVESTMENTS LIMITED And LITHERA, INC. (Filed With SEC on October 17, 2014)
